SLPI and bacterial infectious disease: We have previously reported that RV infection induces secondary bacterial infection in individuals with COPD through neutrophil elastase cleavage of the antimicrobial peptides (AMPs) secretory leucocyte proteinase inhibitor (SLPI) and elafin to promote bacterial growth (18).